ESTRO35 Programme Book

SUNDAY 1 MAY 2016

16:35 > Outcome and prognosticators in adult patients with medulloblastoma: a Rare Cancer Network study B. Atalar (Turkey), M. Ozsahin, J. Call, A. Napieralska, S. Kamer, V. Salvador, P. Erpolat, L. Negretti, Y.L. Ramstad, C. Onal, S. Akyurek, G. Ugurluer, B. Baumert, S. Servagi-Vernat, R.C. Miller, E. Ozyar, T. Sio 16:45 > Tumor bed radiosurgery vs. whole brain radiotherapy after surgery of single brain metastasis L. Kepka (Poland), D. Tyc-Szczepaniak, K. Bujko, M. Olszyna-Serementa, W. Michalski, A. Sprawka, B. Trabska-Kluch, K. Komosinska, E. Wasilewska-Tesluk, B. Czeremszynska 16:55 > Hippocampal dosimetry predicts the change in neurocognitive functions after whole brain radiotherapy S.Y. Lin (Taiwan), C.C. Yang, C.C. Chuang, P.C. Pai, P.F. Tsai, D.L. Tsan, C.K. Tseng 17:05 > Post-radiation neuronal depletion in hippocampus measured by in-vivo magnetic resonance spectroscopy P. Pospisil, T. Kazda (Czech Republic), R. Jancalek, P. Slampa 16:15 > MRI-guided brachytherapy in cervical cancer: high doses to small bowel don’t predict late morbidity C. Petit (France), R. Mazeron, C. Chargari, I. Dumas, P. Maroun, P. Annede, T. Seisen, C. Haie Meder 16:25 > The high doses employed in brachytherapy of cervical cancer counteract hypoxia - a modelling study E. Lindblom (Sweden), A. Dasu, I. Toma-Dasu 16:35 > EBRT and interstitial brachytherapy for recurrent vault carcinomas: Factors influencing the outcomes R. Engineer (India), S. Chopra, U. Mahantshetty, A. Maheshwari, R. Kerkar, R. Phurailatpam, J. Swamidas, S.K. Shrivastava 16:45 > Artificial neural network for bladder dose interfractional variation prediction in GYN brachytherapy Z. Siavashpour (Iran), M.R. Aghamiri, R. Jaberi, R. Ghaderi, C. Kirisits Proffered Papers BRACHYTHERAPY 4: GYNAE-BREAST 16:15 - 17:15 | ROOM 4 Chair: A. Cerrotta (Italy) Chair: H. Westerveld (The Netherlands)

OC-0347

OC-0348

OC-0349

OC-0350

OC-0351

OC-0352

OC-0353

OC-0354

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

113